Irradiated fibroblasts protect burkitt lymphoma cells from apoptosis by a mechanism independent of BCL‐2

When cells of fresh Burkitt lymphoma (BL) biopsies are explanted into tissue culture, their survival and growth are greatly dependent on the presence of a feeder layer of irradiated fibroblasts. To investigate the nature of this feeder dependence, we characterized the growth requirements of a panel of Epstein‐Barr Virus (EBV)‐negative and ‐positive BL cell lines in both the absence and the presence of feeder cells in vitro. Four EBV‐negative BL lines and 4 EBV‐positive lines displaying the phenotype of BL cells in vivo required high cell density for proliferation in the absence of feeder cells, but grew out as single‐cell clones when seeded on irradiated human fibroblasts. EBV‐positive BL cell lines which had acquired an activated phenotype similar to that of lymphoblastoid cell lines required much lower cell densities for autonomous proliferation. The EBV‐negative Burkitt lymphoma line BL70 was used as a model to study the feeder‐cell dependence in more detail. BL70 cells grew in the absence of feeder cells only at high cell density and at high FCS concentration. In the presence of feeder cells, BL70 cells became clonogenic even at greatly reduced FCS concentration. A decrease in either cell density or FCS concentration induced apoptosis. Supernatants from feeder cells and from BL70 cells growing autonomously at high cell density were unable to substitute for the survival and growth‐promoting effect of the feeder cells. Protection of Burkitt lymphoma cells from apoptosis by co‐cultivation with irradiated fibroblasts was not mediated by induction of bcl‐2. The system described here may be relevant for the in vivo situation since Burkitt lymphoma cells are protected from c‐MYC induced apoptosis in vivo also by a mechanism which does not involve bcl‐2.

[1]  C. Gregory,et al.  Prevention of programmed cell death in burkitt lymphoma cell lines by bcl‐2‐dependent and ‐independent mechanisms , 1992, International journal of cancer.

[2]  J. Bonnefoy,et al.  CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.

[3]  G. Klein,et al.  Expression of the epstein‐barr virus (EBV)‐encoded membrane protein LMP1 impairs the In vitro growth, clonability and tumorigenicity of an EBV‐negative burkitt lymphoma line , 1992, International journal of cancer.

[4]  G. Lenoir,et al.  Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. , 1992, Blood.

[5]  F. Behm,et al.  Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. , 1992, Blood.

[6]  H. Stein,et al.  Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease , 1992, Cell.

[7]  S. Markey,et al.  The role of lactic acid in autocrine B-cell growth stimulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Kieff,et al.  The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation , 1991, Journal of virology.

[9]  I. Maclennan,et al.  Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis , 1991, European journal of immunology.

[10]  E. Kieff,et al.  Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.

[11]  Gwyn T. Williams,et al.  Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis , 1991, Nature.

[12]  M. Rowe,et al.  Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. , 1990, The Journal of general virology.

[13]  G. Lenoir,et al.  Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus. , 1990, Blood.

[14]  B. Chait,et al.  Retinol is essential for growth of activated human B cells , 1990, The Journal of experimental medicine.

[15]  D. Hilbert,et al.  In vitro culture of a primary plasmacytoma that has retained its dependence on pristane conditioned microenvironment for growth. , 1990, Current topics in microbiology and immunology.

[16]  I. Magrath The pathogenesis of Burkitt's lymphoma. , 1990, Advances in cancer research.

[17]  W. Hammerschmidt,et al.  Genetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes , 1989, Nature.

[18]  G. Guy,et al.  Interleukin 4 and soluble CD23 as progression factors for human B lymphocytes: analysis of their interactions with agonists of the phosphoinositide “dual pathway” of signalling , 1988, European journal of immunology.

[19]  J. Hatzfeld,et al.  Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line. , 1988, Journal of immunology.

[20]  L. Young,et al.  Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.

[21]  M. Lipinski,et al.  Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. , 1987, Journal of immunology.

[22]  S. Swendeman,et al.  The activation antigen BLAST‐2, when shed, is an autocrine BCGF for normal and transformed B cells. , 1987, The EMBO journal.

[23]  C. Rooney,et al.  Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines. , 1986, Journal of the National Cancer Institute.

[24]  A. Wyllie,et al.  Death and the cell. , 1986, Immunology today.

[25]  G. Lenoir,et al.  The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma. , 1985, IARC scientific publications.

[26]  J. Yates,et al.  Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.

[27]  I Lefkovits,et al.  Limiting dilution analysis of the cells of immune system I. The clonal basis of the immune response. , 1984, Immunology today.

[28]  G. Klein Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men , 1983, Cell.

[29]  J. G. Hirsch,et al.  THE EFFECTS OF MERCAPTOETHANOL AND OF PERITONEAL MACROPHAGES ON THE ANTIBODY-FORMING CAPACITY OF NONADHERENT MOUSE SPLEEN CELLS IN VITRO , 1972, The Journal of experimental medicine.

[30]  J. P. JACOBS,et al.  Characteristics of a Human Diploid Cell Designated MRC-5 , 1970, Nature.